Karthikeyan G, Connolly SJ, Ntsekhe M, Benz A, et al. The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation. Am Heart J 2020;225:69-77.
PMID: 32474206